目的观察HO CO系统在肝硬化病人肝组织中的表达及与门静脉压力的关系，以探讨其在肝硬化门脉高压中的作用。
Purpose To observe the relationship between portal pressure and the expression of HO-CO system in liver of patients with hepatic cirrhosis and the effect on portal hypertension in hepatic cirrhosis.
《国际肝病》：门脉高压及其并发症如静脉曲张出血，腹水和肝性脑病在肝硬化患者较常见。
International Digest: Portal hypertension and its complications such as variceal hemorrhage, ascites, and encephalopathy are common in cirrhosis.
结论检测肝硬化门脉高压症患者的肝组织NO含量、NOS活性可预测其肝脏损伤程度。
Detecting the level of NO and the activity of NOS of patients with hepatic portal hypertension can predict the degree of liver injury.
探讨强肝软坚方对肝硬化门脉高压症的作用及其可能机制。
To study the effect of Qianggan Ruanjian decoction (QRD) on hepatocirrhosis portal hypertension and its possible function mechanism.
目的：探讨光量子血氧疗法（UBIO）在肝硬化门脉高压症术后肝损伤治疗中的应用。
Objective: To study the effect of ultraviolet blood irradiation and oxygenation(UBIO)on liver trauma after operation for symptom of hepatocirrhosis portal hypertension.
病人患有肝硬化和门脉高压症，很可能会发生肝性胸水，最常见的是右侧单侧胸腔积液。
The diagnosis of hepatic hydrothorax should be suspected in a patient with established cirrhosis and portal hypertension, presenting with a unilateral pleural effusion, most commonly right-sided.
材料与方法：对22例临床确诊的肝硬化门脉高压患者行WHVP测定，测量WHVP及肝静脉压力梯度(HVPG)。
Materials and Methods: WHVP and hepatic venous pressure gradient (HVPG) were measured in 22 patients with the cirrhotic portal hypertension.
门脉高压是硬化肝内结构性变化及内脏血流增加的结果。
Portal hypertension occurs as a consequence of structural changes within the liver in cirrhosis and increased splanchnic blood flow.
肝硬化使门脉系统的肝内部分受阻。
The cirrhotic process obstructs the intrahepatic portion of the portal venous system.
肝硬化使门脉系统的肝内部分受阻。
The cirrhotic process obstructs the intrahepatic portion of the portal venous system.
应用推荐